Therapeutic Effect of HGF on NASH Mice Through HGF/c-Met and JAK2-STAT3 Signalling Pathway

Therapeutic Effect of HGF on NASH Mice Through HGF/c-Met and JAK2-STAT3 Signalling Pathway

Introduction and aim. Hepatocyte growth factor (HGF) has been shown to ameliorate liver inflammation and fibrosis; however, the mechanism underlying its effects in non-alcoholic steatohepatitis (NASH) is unclear. This study aimed to analyse the relationship between the JAK2-STAT3 signalling pathway...

Full description

Bibliographic Details
Main Authors: Ning Li, Zhangfeng Dou, Jinchun Liu, Bao Chai, Yue Li, Xiuqin An, Peiling Chu, Xiaolan Zhang
Format: Article
Language:English
Published: Elsevier 2018-05-01
Series:Annals of Hepatology
Subjects:
Non-alcoholic steatohepatitis
Hepatocyte growth factor
HGF/c-Met
JAK2-STAT3 signalling pathway
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119302066

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119302066

Similar Items